ScripNot quite two years after raising $175m in series C cash , inhaled respiratory therapy-focused Avalyn Pharma revealed on July 22 that it has raised a $100m series D round that CEO Lyn Baranowski said
Pink SheetUpcoming federal spending reductions and resulting coverage losses in Medicaid could have a significant impact on patient access to drugs for HIV, cystic fibrosis and mental health, as well as treatme
ScripAt least officially, Bristol Myers Squibb and Pfizer’s are selling the anticlotting drug Eliquis (apixaban) directly to consumers to lower costs for patients, especially those who are uninsured, under
ScripThe future direction for PureTech Health is again under the spotlight as a week after its chair stepped down, the company is now looking for a new CEO following the departure of Bharatt Chowrira. The